Privacy Guidelines For Genetic-Testing Sites Touted As ‘Step Forward,’ But They Don’t Address De-Identified DNA

Samples that are stripped of any identifying details are extremely lucrative to pharmaceutical companies and other medical organizations, but the consumers have no way of knowing when their data is used. In other public health news: birth defects, Ebola, scooter injuries, brain surgery, and more.

from Kaiser Health News https://ift.tt/2KthgsC